| EPSRC Reference: |
EP/L013835/1 |
| Title: |
Understanding polymer - drug interactions and their role in formulation of medicines |
| Principal Investigator: |
Garnett, Professor MC |
| Other Investigators: |
|
| Researcher Co-Investigators: |
|
| Project Partners: |
|
| Department: |
Sch of Pharmacy |
| Organisation: |
University of Nottingham |
| Scheme: |
Standard Research |
| Starts: |
02 June 2014 |
Ends: |
01 January 2018 |
Value (£): |
689,931
|
| EPSRC Research Topic Classifications: |
| Drug Formulation & Delivery |
Materials Characterisation |
| Materials Synthesis & Growth |
|
|
| EPSRC Industrial Sector Classifications: |
| Pharmaceuticals and Biotechnology |
|
|
| Related Grants: |
|
| Panel History: |
|
|
Summary on Grant Application Form |
Formulation of drugs into medicines is necessary to enable them to be taken by patients and to maximise their effectiveness. Medicines are also known as drug delivery systems (DDS). Polymers are used in a variety of DDS, e.g. nanoparticles and matrix systems and in a variety of ways for example to improve drug solubility, provide delivery to a local area or to provide slow release of drug etc. For maximum efficacy of the medicine, a high incorporation of drug and control of drug release (especially slow release) are usually critical in producing clinically useful formulations. Producing such formulations depend on having biocompatible polymers with suitable physicochemical properties compatible with drugs having a diverse range of chemical structures and properties. In this project we aim to develop a better understanding of polymer drug interactions to develop improved DDS.
Solid molecular dispersions will be used in this project as a simple and easily measured DDS dependent on polymer-drug compatibility. A group of poor solubility drugs relevant to solid molecular dispersions have been identified and 25-30 drugs from this group will be selected for this project. To accommodate drugs of different properties, polymers with a range of characteristics will be required. In this project we will use a recently described biodegradable polymer, poly(glycerol adipate) (PGA), having a pendant hydroxyl group which can be chemically modified with acyl or amino acid moieties to generate a family of related polymers with different physicochemical properties.
The project will comprise two tracks of work each with an associated post-doctoral research assistant. The first track will be based on computational modelling, and the second track on the experimental determination of drug polymer interactions. Outputs from both tracks will then be correlated using the experimental determinations to validate the insight and understanding gained from the modelling studies.
The computer modelling will aim to provide an understanding of polymer drug interactions based on a description of the interactions derived from combined atomistic and coarse grained models.. From these models and existing software available at AstraZeneca NRTL-SAC and COSMO-SAC various solubility parameters for the drugs and polymers will be derived.
The second track will consist of synthesis of this family of polymers, the preparation of molecular dispersions of drugs with the polymers and the characterisation of those molecular dispersions for their stability and the experimental determination of their polymer-drug interactions. These characterisations will use a range of (mainly high throughput) spectroscopic, physico-chemical and formulation techniques at Nottingham and AstraZeneca. The solubility parameters and other metrics from the molecular modelling studies which describe the polymers will be correlated with the experimental determination of the properties of the molecular dispersions produced. Molecular modelling is an intensive means of determining compatibility so identification of alternative simpler factors, indicators and methods for predicting drug-polymer compatibility will be investigated. Once appropriate factors have been described these will be used to predict the most compatible polymers for a set of previously undetermined drug molecules chosen from our drug library and validated using the previously identified methodology. The project will thus develop new methodology, validate predictions, enhance understanding of polymer drug interactions and identify new polymer structures which may be useful in both solid dispersions and other polymer based drug delivery systems.
|
|
Key Findings |
|
This information can now be found on Gateway to Research (GtR) http://gtr.rcuk.ac.uk
|
|
Potential use in non-academic contexts |
|
This information can now be found on Gateway to Research (GtR) http://gtr.rcuk.ac.uk
|
|
Impacts |
|
| Description |
This information can now be found on Gateway to Research (GtR) http://gtr.rcuk.ac.uk |
| Summary |
|
| Date Materialised |
|
|
|
|
Sectors submitted by the Researcher |
|
This information can now be found on Gateway to Research (GtR) http://gtr.rcuk.ac.uk
|
| Project URL: |
|
| Further Information: |
|
| Organisation Website: |
http://www.nottingham.ac.uk |